Sexuell übertragbare Krankheiten

  • Constantin E. Orfanos
  • Claus Garbe

Zusammenfassung

Venerische Erkrankungen lassen sich nicht scharf definieren; in den angelsächsischen Ländern wird von „sexually transmitted diseases“ (STD) gesprochen. In Anlehnung daran wurde hier eine Auswahl von Erkrankungen getroffen, bei denen sexuelle Praktiken als häufigster Übertragungsmodus gelten. Da sich venerische Erkrankungen an verschiedenen Organen manifestieren können, werden nicht nur Dermatologen und Venerologen für ihre Behandlung herangezogen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baker-Zander SA, Roddy RE, Handsfield HH, Luke-hart SA (1986) IgG and IgM antibody reactivity to antigens of Treponema pallidum after treatment of syphilis. Sex Transm Dis 13: 214–220PubMedCrossRefGoogle Scholar
  2. Brown ST, Zaidi A, Larsen SA, Reynolds GH (1985) Serological response to syphilis treatment. A new analysis of old data. JAMA 253: 1296–1299Google Scholar
  3. Dunlop EM (1985) Survival of treponemes after treatment: comments, clinical conclusions, and recommandations. Genitourin Med 61: 293–301PubMedGoogle Scholar
  4. Fiumara N (1989) Human immunodeficiency virus infection and syphilis. J Am Acad Dermatol 21: 141–142PubMedCrossRefGoogle Scholar
  5. Fiumara NJ (1986) Treatment of early latent syphilis under 1 year’s duration: serologic response to treatment of 368 patients. J Am Acad Dermatol 15: 1059–1061PubMedCrossRefGoogle Scholar
  6. Fiumara NJ (1986) Treatment of primary and secondary syphilis• serologic response. J Am Acad Dermatol 14: 487–491PubMedCrossRefGoogle Scholar
  7. Frentz G, Nielsen PB, Espersen F et al. (1984) Penicillin concentrations in blood and spinal fluid after a single intramuscular injection of penicillin G benzathin. Eur J Clin Microbiol 3: 147–149PubMedCrossRefGoogle Scholar
  8. Gregory N, Sanchez M, Buchness MR (1990) The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol 22: 1061–1067PubMedCrossRefGoogle Scholar
  9. Janier M (1988) Ceftriaxone is effective for treating patients with primary syphilis. Sex Transm Dis 15: 70PubMedCrossRefGoogle Scholar
  10. Johns DR, Tierney M, Felsenstein D (1987) Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316: 1569–1572PubMedCrossRefGoogle Scholar
  11. Klein VR, Cox SM, Mitchell MD, Wendel GD Jr (1990) The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy. Obstet Gynecol 75: 375–380PubMedGoogle Scholar
  12. Mascola L, Pelosi R, Alexander CE (1984) Inadequate treatment of syphilis in pregnancy. Am J Obstet Gynecol 150: 945–947PubMedGoogle Scholar
  13. Simon RP (1985) Neurosyphilis. Arch Neurol 42: 606–613CrossRefGoogle Scholar
  14. Terry PM, Page ML, Goldmeier D (1988) Are serological tests of value in diagnosing and monitoring response to treatment of syphilis in patients infected with human immunodeficiency virus? Genitourin Med 64: 219–222PubMedGoogle Scholar
  15. Wendel GD Jr, Stark BJ, Jamison RB et al. (1985) Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 312: 1229–1232PubMedCrossRefGoogle Scholar
  16. Wolters EC, Hische EA, Tutuarima JA et al. (1988) Central nervous system involvement in early and late syphilis• the problem of asymptomatic neurosyphilis J Neurol Sci 88: 229–239Google Scholar
  17. Bakhtiar M, Samarasinghe PL (1988) Enoxacin as one day oral treatment of men with anal or pharyngeal gonorrhea. Genitourin Med 64: 364–366PubMedGoogle Scholar
  18. Christophersen J, Bollerup AC, From E et al. (1989) Treating genitourinary and pharyngeal gonorrhea with single dose ceftriaxone. Genitourin Med 65: 14–17PubMedGoogle Scholar
  19. Collier AC, Judson FN, Murphy VL et al. (1984) Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women. Am J Med 77: 68–72PubMedGoogle Scholar
  20. Covino JM, Cummings M, Smith B et al. (1990) Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinaseproducing and non-penicillinase-producing strains. Antimicrob Agents Chemother 34: 148–149PubMedGoogle Scholar
  21. Crider SR, Colby SD, Miller LK et al. (1984) Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. N Engl J Med 311: 137–140PubMedCrossRefGoogle Scholar
  22. Cristiano P (1989) Clinical trial of norfloxacin in the treatment of uncomplicated gonococcal urethritis: preliminary report. Drugs Exp Clin Res 15: 33–35PubMedGoogle Scholar
  23. DeLalla F, Rizzardini G, Angelucci B (1987) Oral ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in men. Chemioterapia 6: 50–51Google Scholar
  24. Gall SA, Constantine L (1990) Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease. Obstet Gynecol 75: 282–286PubMedGoogle Scholar
  25. Goldstein AM, Clark JH, Wickler MA (1991) Comparison of single-dose ceftizoxime or ceftriaxone in the treatment of uncomplicated urethral gonorrhoea. Sex Transm Dis 18: L180–182CrossRefGoogle Scholar
  26. Gunning JE (1986) A comparison of piperacillin and clindamycin plus gentamycin in women with pelvic infections. Surg Gynecol Obstet 163: 156–162PubMedGoogle Scholar
  27. Haase DA, Nach RA, Nsanze H et al. (1986) Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum. Sex Transm Dis 13: 53–55PubMedCrossRefGoogle Scholar
  28. Handsfield HH, McCormack WM, Hook EW et al. (1991) A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. N Engl J Med 325: 1337–1341PubMedCrossRefGoogle Scholar
  29. Judson FN, Ehret JM, Handsfield HH (1985) Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea. JAMA 253: 1417–1419PubMedCrossRefGoogle Scholar
  30. Kaplowitz LG, Vishniaysky N, Evans T et al. (1987) Norfloxacin in the treatment of uncomplicated gonococcal infections. Am J Med 82: 35–39PubMedCrossRefGoogle Scholar
  31. Kouri YH, Gonzalez L, Perez M et al. (1989) Effect of penicillin and spectinomycin given for urethritis and cervicitis with Neisseria gonorrhoeae: high prevalence of penicillin-resistant isolates. Genitourin Med 65: 342–346PubMedGoogle Scholar
  32. Loo PS, Ridgeway GL, Oriel JD (1985) Single dose ciprofloxacin for treating gonococcal infections in men. Genitourin Med 61: 302–305PubMedGoogle Scholar
  33. Orfanos CE, Adler M, Hörnle R et al. (1989) Spectinomycin-resistente Gonokokken-Infektionen in der Bundesrepublik Deutschland. Hautarzt 40: 713–717PubMedGoogle Scholar
  34. Pabst KM, Siegel NA, Smith S et al. (1989) Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea. Sex Transm Dis 16: 148–151PubMedCrossRefGoogle Scholar
  35. Panikabutra K, Ariyarit C, Chitwarakorn A et al. (1985) Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea. Genitourin Med 61: 106–108PubMedGoogle Scholar
  36. Panikabutra K, Lee CT, Ho B, Bamberg P (1988) Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): Analysis of efficacy and patient preference. Genitourin Med 64: 235–240Google Scholar
  37. Plourde PJ, Tyndall M, Agoki ER (1992) Single dose cefixime versus single dose ceftriaxon in the treatment of antimicrobial resistant Neisseria gonorrheae infection. J Infect Dis 166: 199–202Google Scholar
  38. Sweet RL, Schachter J, Landers DV et al. (1988) Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. Am J Obstet Gynecol 158: 736–741PubMedGoogle Scholar
  39. Wollner-Hansen P, Paavonen J, Kiviat N et al. (1989) Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Obstet Gynecol 71: 595–600Google Scholar
  40. Ziegler C, Stary A, Mailer H et al. (1992) Quinolones as an alternative treatment of chlamydial, mycoplasma and gonococcal infections. Dermatologica 185: 128–131CrossRefGoogle Scholar
  41. Bowmer MI, Nsanze H, D’Costa LJ et al. (1987) Single-dose ceftriaxone for chancroid. Antimicrob Agents Chemother 31: 67–69PubMedGoogle Scholar
  42. Boyd AS (1989) Clinical efficacy of antimicrobial therapy in Haemophilus ducreyi infections. Arch Dermatol 125: 1399–1405PubMedCrossRefGoogle Scholar
  43. Dylewski J, Nsanze H, D’Costa L et al. (1985) Trimethoprim sulphamoxazole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen. J Antimicrob Chemother 16: 103–109PubMedCrossRefGoogle Scholar
  44. Fuimara NJ, Rothman K, Tang S (1986) The diagnosis and treatment of chancroid. J Am Acad Dermatol 15: 939–943CrossRefGoogle Scholar
  45. Hartmann AA, Elsner P, Burg G (1991) Intravenous single-dose ceftriaxone treatment of chancroid. Dermatologica 183: 132–135PubMedCrossRefGoogle Scholar
  46. Korting HC, Abeck D, Neubert U et al. (1989) Diagnose and Therapie des Ulcus molle heute. Kasuistik and Literaturübersicht. Hautarzt 40: 418–422PubMedGoogle Scholar
  47. Kumar B, Sharma VK, Bakaya V (1990) Sulphaphenazole, streptomycin and sulphaphenazole combination, trimethoprim, and erythromycin in the treatment of chancroid. Genitourin Med 66: 105–107PubMedGoogle Scholar
  48. Naamara W, Plummer FA, Greenblatt RM et al. (1987) Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial. Am J Med 82: 317–320PubMedGoogle Scholar
  49. Ndinya-Achola JO, Nsanze H, Karasira P et al. (1986) Three day oral course of augmentin to treat chancroid. Genitourin Med 62: 202–204PubMedGoogle Scholar
  50. Plourde PJ, D’Costa LJ, Agoki E et al. (1992) A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 165: 949–952PubMedCrossRefGoogle Scholar
  51. Ronald AR, Plummer FA (1989) Chancroid and granuloma inguinale. Clin Lab Med 9: 535–543PubMedGoogle Scholar
  52. Schmid GP (1986) The treatment of chancroid. JAMA 255: 1757–1762PubMedCrossRefGoogle Scholar
  53. Taylor DN, Pitarangsi C, Echeverria P et al. (1985) Comparative study of ceftriaxone and trimethoprimsulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis 152: 1002–1006PubMedCrossRefGoogle Scholar
  54. Faro S (1990) Lymphogranuloma venereum, chancroid, and granuloma inguinale. Obstet Gynecol Clin North Am 16: 517–530Google Scholar
  55. Gschnait F (1986) Genitale Chlamydieninfektionen. Hautarzt 37: 312–319PubMedGoogle Scholar
  56. Hartmann AA (1989) Chlamydieninfektionen in der Dermatologie. Z Hautkr 64: 391–392Google Scholar
  57. Linnemann CC Jr, Heaton CL, Ritchey M (1987) Treatment of chlamydia trachomatis infections: comparison of 1- and 2-g doses of erythromycin daily for seven days. Sex Transm Dis 14: 102–106PubMedCrossRefGoogle Scholar
  58. Lisby SM, Nahata MC (1987) Recognition and treatment of chlamydial infections. Clin Pharm 6: 25–36PubMedGoogle Scholar
  59. Latif AS, Mason PR, Paraiwa E (1988) The treatment of donovanosis (granuloma inguinale). Sex Transm Dis 15: 27–29PubMedCrossRefGoogle Scholar
  60. O’Farrell N (1991) Failure of single dose ceftriaxone in donovanosis (granuloma inguinale). Genitourin Med 67: 269–270PubMedGoogle Scholar
  61. Richens L (1991) The diagnosis and treatment of donovanosis (granuloma inguinale). Genitourin Med 67: 441–452PubMedGoogle Scholar
  62. Ronald AR, Plummer FA (1989) Chancroid and granuloma inguinale. Clin Lab Med 9: 535–543PubMedGoogle Scholar
  63. Rosen T, Tschen JA, Ramadell W et al. (1984) Granu-loma inguinale. J Am Acad Dermatol 11: 433–437PubMedCrossRefGoogle Scholar
  64. Sehgal VN, Prasad AL (1986) Donovanosis. Current concepts. Int J Dermatol 25: 8–16Google Scholar
  65. Boslego JW, Hicks CB, Greenup R et al. (1988) A prospective randomized trial of ofloxacin vs. doxycycline in the treatment of uncomplicated male urethritis. Sex Transm Dis 15: 186–191PubMedCrossRefGoogle Scholar
  66. Bowie WR (1984) Epidemiology and therapy of Chla- mydia trachomatis infections. Drugs 27: 459–468PubMedCrossRefGoogle Scholar
  67. Bowie WR, Yu JS, Jones HD (1986) Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritis. Sex Transm Dis 13: 76–80PubMedCrossRefGoogle Scholar
  68. Cates W Jr, Wasserheit JN (1991) Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 164: 1771–1781PubMedGoogle Scholar
  69. Gschnait F (1986) Genitale Chlamydieninfektionen. Hautarzt 37: 312–319PubMedGoogle Scholar
  70. Hartmann AA (1989) Chlamydieninfektionen in der Dermatologie. Z Hautkr 64: 388–392PubMedGoogle Scholar
  71. Katz BP, Caine VA, Batteiger BE, Jones RB (1991) A randomized trial to compare 7- and 21-day tetracycline regimens in the prevention of recurrence of infection with Chlamydia trachomatis. Sex Transm Dis 18: 36–40PubMedCrossRefGoogle Scholar
  72. Kollmann M, Korting HC (1993) Diagnosik und Therapie der Urethritis. Z Hautkr 11: 705–710Google Scholar
  73. Martens MG, Faro S, Hammill H et al. (1990) Comparison of cefotaxime, cefoxitin and clindamycin plus gentamycin in the treatment of uncomplicated and complicated pelvic inflammatory disease. J Antimicrob Chemother 26: 37–43PubMedGoogle Scholar
  74. Mogabgab WJ, Holmes B, Murray M et al. (1990) Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. Chemotherapy 36: 70–76PubMedCrossRefGoogle Scholar
  75. Noguera X, Ferrer M, Ortola E, Lopez-Martin L (1986) Evaluation of doxycycline in the treatment of urethritis and cervicitis caused by Chlamydia trachomatis. Clin Ther 9: 33–37PubMedGoogle Scholar
  76. Oehme A, Musholt PB, Dreesbach K (1991) Chlamydiae as pathogens — an overview of diagnostic techniques, clinical features, and therapy of human infections. Klin Wochenschr 69: 463–473PubMedCrossRefGoogle Scholar
  77. Ossewaarde JM, Plantema FHF, Rieffe M et al. (1992) Efficacy of single-dose azithromyzin vs. doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 11: 693–697PubMedCrossRefGoogle Scholar
  78. Sanders LL, Harrison HR, Washington AE (1986) Treatment of sexually transmitted chlamydial infections. JAMA 255: 1750–1756PubMedCrossRefGoogle Scholar
  79. Stenberg K, Mardh PA (1990) Chlamydial conjunctivitis in neonates and adults. History, clinical findings and follow-up. Acta Ophthalmol (Copenh) 68: 651–657Google Scholar
  80. Sweet RL, Schachter J, Landers DV et al. (1988) Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline. Am J Obstet Gynecol 158: 736–741PubMedGoogle Scholar
  81. Wendel GD Jr, Cox SM, Bawdon RE et al. (1991) A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. Am J Obstet Gynecol 164: 1390–1396PubMedGoogle Scholar
  82. Wolner-Hanssen P, Paavonen J, Kiviat N et al. (1988) Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Obstet Gynecol 71: 595–600PubMedGoogle Scholar
  83. Worm AM, Anstorp C, Petersen CS (1985) Erythromycin against Chlamydia trachomatis infections. A double blind study comparing 4- and 7-day treatment in men and women. Dan Med Bull 32: 269–271PubMedGoogle Scholar
  84. Worm AM, Hoff G, Kroon S et al. (1989) Roxithromycin compared with erythromycin against genitourinary chlamydial infections. Genitourin Med 65: 35–38PubMedGoogle Scholar
  85. Ziegler C, Stary A, Mailer H et al. (1992) Quinolones as an alternative treatment of chlamydial, mycoplasma and gonococcal infections. Dermatologica 185: 128–131CrossRefGoogle Scholar
  86. Crawshaw SC, Stocker DI, Sugrue DL, Haran MV (1990) Evaluation of the significance of Mycoplasma hominis and Ureaplasma urealyticum in female genital tract infection — a retrospective case note study. Int J STD AIDS 1: 191–194PubMedGoogle Scholar
  87. Elsner P, Hartmann AA, Burg G (1990) Erfahrungen mit der Oxytetrazyklin-Therapie der nichtgonorrhoischen Urethritis durch Ureaplasma urealyticum. Hautarzt 41: 94–97PubMedGoogle Scholar
  88. Eschenbach DA, Nugent RP, Rao AV et al. (1991) A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 164: 734–742PubMedGoogle Scholar
  89. Mogabgab WJ, Holmes B, Murray M et al. (1990) Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis. Chemotherapy 36: 70–76PubMedCrossRefGoogle Scholar
  90. Moller BR, Herrmann B, Ibsen HH et al. (1990) Occurence of Ureaplasma urealyticum and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin. Scand J Infect Dis 68: 31–34Google Scholar
  91. Risi GF Jr, Sanders CV (1989) The genital mycoplas- mas. Obstet Gynecol Clin North Am 16: 611–626PubMedGoogle Scholar
  92. Robertson JA (1988) Alternative therapy for genital mycoplasma infections. Eur J Clin Microbiol Infect Dis 7: 603–605PubMedCrossRefGoogle Scholar
  93. Ahmed-Jussuf IH, Murray AE, McKeown J (1988) Managing trichomonal vaginitis refractory to conventional treatment with metronidazole. Genitourin Med 64: 25–29Google Scholar
  94. Bloch B, Smyth E (1985) The treatment of Trichomonas vaginalis vaginitis. An open controlled prospective study comparing a single dose of metronidazole tablets, benzoyl metronidazole suspension and tinidazole tablets. S Mr Med J 67: 455–457Google Scholar
  95. Dombrowski MP, Sokol RJ, Brown WJ, Bronsteen RA (1987) Intravenous therapy of metronidazole-resistant Trichomonas vaginalis. Obstet Gynecol 69: 524–525PubMedGoogle Scholar
  96. Grossman JH, Galask RP (1990) Persistent vaginitis caused by metronidazole-resistant trichomonas. Obstet Gynecol 76: 521–522PubMedGoogle Scholar
  97. Larsen B, Wilson AH, Glover DD, Charles D (1986) Implications of metronidazole pharmacodynamics for therapy of trichomoniasis. Gynecol Obstet Invest 21: 12–18PubMedCrossRefGoogle Scholar
  98. Latif AS, Mason PR, Marowa E (1987) Urethral trichomoniasis in men. Sex Transm Dis 14: 9–11PubMedCrossRefGoogle Scholar
  99. Lossick JG (1990) Treatment of sexually transmitted vaginosis/vaginitis. Rev Infect Dis 12: 5665–681CrossRefGoogle Scholar
  100. Lossick JG, Muller M, Gorrell TE (1986) In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 153: 948–955PubMedCrossRefGoogle Scholar
  101. Rossignol JF, Maisonneuve H, Cho YW (1984) Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis. Int J Clin Pharmacol Ther Toxicol 22: 63–72PubMedGoogle Scholar
  102. Weihe J, Metelmann C, Borner K et al. (1988) Metronidazol-resistente Trichomoniasis und erfolgreiche Therapie nach hoher Dosierung. Hautarzt 39: 237–239PubMedGoogle Scholar
  103. Hansen JG, Schmidt H (1985) Treatment of the Gardnerella vaginalis syndrome. A controlled, double-blind study comparing pivampicillin and metronidazole. Scand J Prim Health Care 3: 151–154PubMedCrossRefGoogle Scholar
  104. Hartmann AA, Elsner P (1984) Gardnerella vaginalis- Infektion: eine weitere STD. Hautarzt 35: 512–516PubMedGoogle Scholar
  105. Mohanty KC, Deighton R (1985) Comparison of two different metronidazole regimens in the treatment of Gardnerella vaginalis infection with or without trichomoniasis. J Antimicrob Chemother 16: 799–803PubMedCrossRefGoogle Scholar
  106. Nayagam AT, Smith MD, Ridgway GL et al. (1992) Comparison of ofloxacin and metronidazole for the treatment of bacterial vaginosis. Int J STD AIDS 3: 204–207PubMedGoogle Scholar
  107. Thomason JL, Gelbhart SM, Scaglione (1991) Bacterial vaginosis: current review with indications for asymptomatic therapy. Am J Obstet Gynecol 165: 1210–1217Google Scholar
  108. Thomason JL, Gelbhart SM, Scaglione NJ et al. (1990) Vaginitis in reproductive-age women. Curr Opin Obstet Gynecol 2: 656–661PubMedGoogle Scholar
  109. Editorial (1992) AIDS-Risiko: Kindesmißbrauch. Psychologie heute 6: 15Google Scholar
  110. Goldenring J (1991) Condylomata acuminata. Pediatric Forum 145: 600–601Google Scholar
  111. Gutman LT, StClaire KK, Weedy C et al. (1991) Human immunodeficiency virus transmission by child sexual abuse. Am J Dis Child 145: 137–141PubMedGoogle Scholar
  112. Kulhanjian JA, Hilton NS (1991) Gonococcal salpingitis in premenarchal female following sexual assault. Clin Ped 1: 53–55CrossRefGoogle Scholar
  113. Nelson JD, Mohs E, Dajani A, Plotkin SA (1976) Gonorrhea in preschool and schoolaged children. JAMA 76: 1359–1364CrossRefGoogle Scholar
  114. Reinhard MA (1991) Medical evaluation of young sexual abuse victims: a view entering the 1990’s. Med Sci Law 31: 81–86Google Scholar
  115. Robinson R (1991) Physical signs of sexual abuse in children. BMJ 302: 863–864PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Constantin E. Orfanos
    • 1
  • Claus Garbe
    • 1
  1. 1.Universitäts-Hautklinik und PoliklinikKlinikum Benjamin Franklin der Freien Universität BerlinBerlinDeutschland

Personalised recommendations